Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Gullestad

Showing results (311-320 of 382) with videos related to

Pageof 39
Sort By:
Journal of Cardiovascular Translational Research|May 6, 2017
The Notch Ligands DLL1 and Periostin Are Associated with Symptom Severity and Diastolic Function in Dilated CardiomyopathyHilde M Norum, Kaspar Broch, Annika E Michelsen, et al.
European Heart Journal|April 20, 2012
Galectin-3 predicts response to statin therapy in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)Lars Gullestad, Thor Ueland, John Kjekshus, et al.
Plos One|November 15, 2014
The homeostatic chemokine CCL21 predicts mortality in aortic stenosis patients and modulates left ventricular remodelingAlexandra Vanessa Finsen, Thor Ueland, Ivar Sjaastad, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 13, 2018
Circulating delta-like Notch ligand 1 is correlated with cardiac allograft vasculopathy and suppressed in heart transplant recipients on everolimus-based immunosuppressionHilde M Norum, Annika E Michelsen, Tove Lekva, et al.
International Journal of Cardiology|October 7, 2024
Effect of tocilizumab on endothelial and platelet-derived CXC-chemokines and their association with inflammation and myocardial injury in STEMI patients undergoing primary PCISindre Woxholt, Thor Ueland, Pål Aukrust, et al.
Ebiomedicine|July 27, 2019
Early increase of specialized pro-resolving lipid mediators in patients with ST-elevation myocardial infarctionLinn E Fosshaug, Romain A Colas, Anne K Anstensrud, et al.
Journal of the American College of Cardiology|October 19, 2006
Increased levels of neutrophil-activating peptide-2 in acute coronary syndromes: possible role of platelet-mediated vascular inflammationCamilla Smith, Jan K Damås, Kari Otterdal, et al.
ESC Heart Failure|March 11, 2025
Transthyretin amyloid cardiomyopathy in aortic stenosis patients scheduled for transcatheter aortic valve implantationMargrethe Flesvig Holt, August Flø, Esra Kaya, et al.
Heart Rhythm|June 18, 2022
Effect of continuous positive airway pressure therapy on recurrence of atrial fibrillation after pulmonary vein isolation in patients with obstructive sleep apnea: A randomized controlled trialTove-Elizabeth Hunt, Gunn Marit Traaen, Lars Aakerøy, et al.
JACC. Heart Failure|April 12, 2014
Fatigue as a predictor of outcome in patients with heart failure: analysis of CORONA (Controlled Rosuvastatin Multinational Trial in Heart Failure)Ana Cristina Perez-Moreno, Pardeep S Jhund, Michael R Macdonald, et al.
Pageof 39

Showing results (311-320 of 382) with videos related to

Sort By:
Pageof 39
Journal of Cardiovascular Translational Research|May 6, 2017
The Notch Ligands DLL1 and Periostin Are Associated with Symptom Severity and Diastolic Function in Dilated CardiomyopathyHilde M Norum, Kaspar Broch, Annika E Michelsen, et al.
European Heart Journal|April 20, 2012
Galectin-3 predicts response to statin therapy in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)Lars Gullestad, Thor Ueland, John Kjekshus, et al.
Plos One|November 15, 2014
The homeostatic chemokine CCL21 predicts mortality in aortic stenosis patients and modulates left ventricular remodelingAlexandra Vanessa Finsen, Thor Ueland, Ivar Sjaastad, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 13, 2018
Circulating delta-like Notch ligand 1 is correlated with cardiac allograft vasculopathy and suppressed in heart transplant recipients on everolimus-based immunosuppressionHilde M Norum, Annika E Michelsen, Tove Lekva, et al.
International Journal of Cardiology|October 7, 2024
Effect of tocilizumab on endothelial and platelet-derived CXC-chemokines and their association with inflammation and myocardial injury in STEMI patients undergoing primary PCISindre Woxholt, Thor Ueland, Pål Aukrust, et al.
Ebiomedicine|July 27, 2019
Early increase of specialized pro-resolving lipid mediators in patients with ST-elevation myocardial infarctionLinn E Fosshaug, Romain A Colas, Anne K Anstensrud, et al.
Journal of the American College of Cardiology|October 19, 2006
Increased levels of neutrophil-activating peptide-2 in acute coronary syndromes: possible role of platelet-mediated vascular inflammationCamilla Smith, Jan K Damås, Kari Otterdal, et al.
ESC Heart Failure|March 11, 2025
Transthyretin amyloid cardiomyopathy in aortic stenosis patients scheduled for transcatheter aortic valve implantationMargrethe Flesvig Holt, August Flø, Esra Kaya, et al.
Heart Rhythm|June 18, 2022
Effect of continuous positive airway pressure therapy on recurrence of atrial fibrillation after pulmonary vein isolation in patients with obstructive sleep apnea: A randomized controlled trialTove-Elizabeth Hunt, Gunn Marit Traaen, Lars Aakerøy, et al.
JACC. Heart Failure|April 12, 2014
Fatigue as a predictor of outcome in patients with heart failure: analysis of CORONA (Controlled Rosuvastatin Multinational Trial in Heart Failure)Ana Cristina Perez-Moreno, Pardeep S Jhund, Michael R Macdonald, et al.
Pageof 39